An official website of the United States government.

We've made some changes to EPA.gov. If the information you are looking for is not here, you may be able to find it on the EPA Web Archive or the January 19, 2017 Web Snapshot.

Endocrine Disruption

Standard Evaluation Procedures (SEPs) and Data Entry Spreadsheet Templates (DESTs) for Endocrine Disruptor Screening Program (EDSP) Tier 1 Assays

On this page you will find information on:

Standard Evaluation Procedures (SEPs)

  • Developed by EPA's Office of Chemical Safety and Pollution Prevention (OCSPP)
  • Provide guidance for the review and evaluation of environmental and human health effects data submitted in response to test orders for the 890 Guideline Series for the Endocrine Disruptor Screening Program (EDSP) Tier 1 battery. 
    • There is an individual SEP for each of the eleven 890 Guideline Series EDSP Tier 1 assays that comprise the battery.
  • Assist EPA reviewers and support comprehensive and consistent evaluations of major scientific topics.
  • Provide interpretive scientific and policy guidance where appropriate.
  • Provide a venue for standardizing data organization and evaluation procedures with the goal of increasing the efficiency, thoroughness and consistency with which individual study evaluations are prepared and assist the scientists to reach clear, reasonable and concise conclusions that are scientifically robust.

The SEPs do not provide guidance for making the determination that a chemical which has been screened using the EDSP Tier 1 assays should move on to Tier 2 testing. The Agency submitted a separate draft guidance document of the Weight-of-Evidence (WoE) for public review and comment as described in a Federal Register Notice issued November 4, 2010 (75 FR 67963).

Top of Page

Data Evaluation Records (DERs)

SEPs may also have utility to other offices in the Agency. Using the guidance within the relevant SEP, Agency reviewers will develop Data Evaluation Records (DERs) for each of the submitted assays. The DERs will:

  • Reflect how well the assay conforms to the Series 890 EDSP Test Guidelines and document basic study information such as materials, methods, results, significant deviations from the study protocol or guideline recommendations as well as their potential impacts.
  • Provide the registrant’s conclusions, the EPA reviewer’s conclusions and any other information about the performance of the study that affects interpretation of the data within the context of the EDSP.

Top of Page

Data Entry Spreadsheet Templates (DESTs)

OCSPP has also developed a set of Data Entry Spreadsheet Templates (DESTs) that test order recipients may choose to use as a method for reporting all raw data in electronic format for the 890 Guideline Series for the EDSP Tier 1 battery. There is a DEST for each of the eleven 890 Guideline Series EDSP Tier 1 assays that comprise the battery. EPA is encouraging test order recipients to use the DEST as a method for standardizing raw data reporting and to assist EPA reviewers in the comprehensive and consistent evaluations of the raw data.

Top of Page

Study Profile Templates (SPTs)

The study profile templates (SPTs) describe the layout and scope of information that should be contained within a study profile and can serve as a guide for the preparation of study documents. Applicants may include additional information beyond that prescribed in a particular study profile; however, it should be done without affecting or changing the format and content of the template.

Top of Page

Series 890 - Endocrine Disruptor Screening Program Test Guidelines

Sort alphabetically or by Guideline Number by using the column headings. Find an assay by using the search function, or use both features together.

Guideline Number Assay Standard Evaluation Procedures (SEPs) Data Entry Spreadsheet Templates (DESTs) Study Profile Templates (SPTs)
890.1100 Amphibian Metamorphosis September 2011 Version October 2011 Version September 2011 Version
890.1150 Androgen Receptor Binding (Rat Prostate) October 2011 Version September 2011 Version October 2011 Version
890.1200 Aromatase (Human Recombinant) August 2011 Version September 2011 Version July 2011 Version
890.1250 Estrogen Receptor Binding October 2011 Version September 2011 Version October 2011 Version
890.1300 Estrogen Receptor Transcriptional Activation (Human Cell Line HeLa-9903) September 2011 Version September 2011 Version August 2011 Version
890.1350 Fish Short-Term Reproduction October 2011 Version September 2011 Version October 2011 Version
890.1400 Hershberger (Rat) October 2011 Version September 2011 Version October 2011 Version
890.1450 Female Pubertal (Rat) August 2011 Version September 2011 Version August 2011 Version
890.1500 Male Pubertal (Rat) August 2011 Version September 2011 Version August 2011 Version
890.1550 Steroidogenesis (Human Cell Line – H295R) August 2011 Version September 2011 Version July 2011 Version
890.1600 Uterotrophic (Rat) September 2011 Version September 2011 Version September 2011 Version

The SEPs, DESTs, and other EDSP guidance documents will be open to periodic updating and revision to reflect advances in the science as it come available. The SEPs and DESTs provide general guidance and are not binding on either the Agency or any outside parties. The use of language such as "will," "is," "may," "can" or "should" in the SEPs or DESTs does not connote any requirement for either EPA or any outside parties.  As such, EPA may depart from the guidance or revise these templates where circumstances warrant and without prior notice.

Top of Page